Detailed information
| LncRNA Name | GAS5 |
| Variant Type | SNP |
| Variant ID | rs1456204276 |
| Species | human |
| Circulating | ✕ |
| Survival | ✕ |
| CeRNA | ✕ |
| Methylation | ✕ |
| Enhancer | ✕ |
| Drug | ✕ |
| Disease/Trait | hepatocellular carcinoma |
| LncRNA Target Gene | NA |
| Tissue | hepatocellular carcinoma tissue, (Sk-Hep-1, BEL-7404, Huh7) cell lines |
| Experiment | genotyping. Real-time PCR, western blot, luciferase reporter assay |
| Function Description | Rs145204276 may contribute to hepatocarcinogenesis by affecting methylation status of the GAS5 promoter and subsequently its transcriptional activity thus serving as a potential therapy target for HCC. |
| Pubmed ID | 26163879 |
| Year | 2015 |
| Title | Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma |
| External Links | |
|---|---|
| Links For GAS5 | GeneCards HGNC NONCODE LncRNAWiki lncrnadb |
| Links For hepatocellular carcinoma | OMIM Cosmic |
| Links For rs1456204276 | dbSNP ClinVar OMIM |